Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Canadian Journal of Cardiology

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0828-282X(08)70624-XPMID 18548147PMCID PMC2643194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renin inhibition in hypertension.

  2008cited by this paper
• Gender Differences in the Renin-Angiotensin and Nitric Oxide Systems: Relevance in the Normal and Diseased Kidney

  2007cited by this paper
• Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature

  2007cited by this paper
• Effect of age at menopause on blood pressure in postmenopausal women.

  2007cited by this paper
• Angiotensin‐converting enzyme inhibitors and survival in women and men with heart failure

  2007cited by this paper
• Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure — A population study

  2007cited by this paper
• A comprehensive view of sex-specific issues related to cardiovascular disease

  2007cited by this paper
• Adherence to Federal Guidelines for Reporting of Sex and Race/Ethnicity in Clinical Trials

  2006cited by this paper
• Gender differences in the renal response to renin-angiotensin system blockade.

  2006cited by this paper
• Abstract 2734: Heart Failure with Preserved and Impaired Left Ventricular Systolic Function in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2006cited by this paper
• The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends

  2006cited by this paper
• Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

  2006influential reference
• Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

  2005cited by this paper
• The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients

  2005cited by this paper
• Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients

  2005cited by this paper
• Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

  2005influential reference
• Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

  2004cited by this paper
• Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

  2003cited by this paper
• Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

  2003cited by this paper
• Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

  2003cited by this paper
• Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

  2003cited by this paper
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• Definition and epidemiology of hypertensive cardiovascular disease in women: the size of the problem.

  2002cited by this paper
• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Gender Differences in the Regulation of Blood Pressure

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• Distribution of blood pressure and hypertension in Canada and the United States.

  2001cited by this paper
• Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

  1998cited by this paper
• Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

  1998cited by this paper
• Awareness, treatment, and control of hypertension in Canada.

  1997cited by this paper
• The role of the NIH's Office of Research on Women's Health

  1994cited by this paper
• The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension. The CAPPP Group.

  1990cited by this paper

• The relationship between estrogen and renin angiotensin system components in the context of hypertension

  2025cites this paper
• Novel Advances in Our Understanding of Sex-Dependent Control of Blood Pressure.

  2025cites this paper
• Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair

  2025cites this paper
• Increased absorptive transcytosis and tight junction weakness in heart failure are equally corrected by exercise training and losartan

  2025cites this paper
• Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology

  2024cites this paper
• Women's health and kidney protective medications

  2024cites this paper
• Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials

  2024cites this paper
• The global magnitude and temporal trend of hypertensive heart disease burden attributable to high sodium intake from 1990 to 2021.

  2024cites this paper
• Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fraction

  2024cites this paper
• Elevated blood pressure accelerates white matter brain aging among late middle-aged women: a Mendelian Randomization study in the UK Biobank

  2023cites this paper
• Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on respiratory Mucin-5ac, Mucin-C5b and Forkhead box protein-A2 of a hamster tracheal mucosa.

  2023cites this paper
• Striatin Gene Variants Are Associated With Salt Sensitivity of Blood Pressure by Mechanisms That Differ in Women and Men

  2023cites this paper
• Efficacy of fosinopril and amlodipine in pediatric primary hypertension: a single-center observational study

  2023cites this paper
• Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis

  2023cites this paper
• Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases

  2023cites this paper
• Sex and gender differences in the treatment of arterial hypertension

  2023cites this paper
• Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial

  2022cites this paper
• Influence of sex on renin‐angiotensin‐aldosterone system metabolites and enzymes in Doberman Pinschers

  2022cites this paper
• Hypertension in Women: The Current Understanding and Future Goals

  2022cites this paper
• Sex differences in hypertension. Do we need a sex-specific guideline?

  2022cites this paper
• Associations of Sex, Age, and Cardiometabolic Risk Profiles With Brain Structure and Cognition

  2022cites this paper
• Sex, Renin Angiotensin System Inhibitors, and COVID-19 Severity: Biologic Divergence or Healthcare Disparity?*

  2022cites this paper
• Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19*

  2022cites this paper
• Ischemic Heart Disease Related Sudden Cardiac Death in Autopsied Cases

  2021cites this paper
• SARS-CoV-2 infection and smoking: What is the association? A brief review

  2021cites this paper
• Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.

  2021cites this paper
• Gender-based differences in the effectiveness of antihypertensive therapy with losartan compared with enalapril

  2021cites this paper
• Sex-Gender Awareness in Diabetes

  2021cites this paper
• Prevalence and Presentation of Paediatric Coronavirus Disease 2019 in Lagos, Nigeria

  2021cites this paper
• The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman

  2021cites this paper
• The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy.

  2021cites this paper
• Sex differences in cardiovascular actions of the renin–angiotensin system

  2020cites this paper
• Is Sex a Determinant of COVID-19 Infection? Truth or Myth?

  2020cites this paper
• Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?

  2020cites this paper
• Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review

  2020influential citation
• Targeting the renin angiotensin system for the treatment of anxiety and depression.

  2020cites this paper
• Gender Issues in Chronic Kidney Disease

  2020cites this paper
• Influence of Sex on the Progression of Chronic Kidney Disease.

  2019cites this paper
• Sex differences in the metabolic effects of the renin-angiotensin system

  2019cites this paper
• Peripheral arterial disease.

  2019cites this paper
• Sex and Gender Driven Modifiers of Alzheimer’s: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks

  2019cites this paper
• Sex-specific differences in endoplasmic reticulum aminopeptidase 1 modulation influence blood pressure and renin-angiotensin system responses.

  2019cites this paper
• Gender‐specific therapeutic approach in arterial hypertension – Challenges ahead

  2019cites this paper
• Why Do Patients With Well-Controlled Vascular Risk Factors Develop Progressive Chronic Kidney Disease?

  2019cites this paper
• Sex-specific differences in hypertension and associated cardiovascular disease

  2018cites this paper
• The Effect of Sex and Gender on Diabetic Complications.

  2017cites this paper
• From head to toe: Sex and gender differences in the treatment of ischemic cerebral disease

  2017cites this paper
• Niereninsuffizienz und Dialyse

  2017cites this paper
• Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature.

  2016cites this paper
• The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk.

  2016cites this paper
• Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.

  2016cites this paper
• Ageing-related cardiomyocyte functional decline is sex and angiotensin II dependent

  2014cites this paper
• Aging-related cardiomyocyte functional decline is sex- and angiotensinII-dependent

  2014cites this paper
• Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.

  2014cites this paper
• Postmenopausal Hypertension and Sodium Sensitivity

  2014cites this paper
• Development and Evaluation of ‘Briefing Notes’ as a Novel Knowledge Translation Tool to Aid the Implementation of Sex/Gender Analysis in Systematic Reviews: A Pilot Study

  2014cites this paper
• Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.

  2013cites this paper
• Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension.

  2012cites this paper
• Cardiovascular risk in women with diabetes.

  2010cites this paper
• Sex differences in the treatment of arterial hypertension

  year unknowncites this paper